Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Category: Vensana Capital® Portfolio News

Vensana Capital® Portfolio News

Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions

Vensana Capital® Portfolio News

Evident Vascular Raises Series B Financing to Advance AI-Powered Intravascular Ultrasound Platform Technology

Vensana Capital® Portfolio News

Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program

Vensana Capital® Portfolio News

Evident Vascular Welcomes Scott R. Ward to its Board of Directors

Vensana Capital® Portfolio News

Cleerly Raises $106 Million in Funding Led by Insight Partners to Revolutionize Heart Disease Care

Vensana Capital® Portfolio News

Okami Medical Appoints Bill Hoffman to its Board of Directors

Vensana Capital® Portfolio News

Okami Medical Announces Closing Of $32.5M Financing

Vensana Capital® Portfolio News

Stryker completes acquisition of Artelon, Inc.

Vensana Capital® Portfolio News

Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons

Vensana Capital® Portfolio News

Clinical Trial Finds Artificial Intelligence-Guided Procedure for Persistent Atrial Fibrillation Superior to Current Standard of Care

Vensana Capital® Portfolio News

iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors

Vensana Capital® Portfolio News

Elucent Medical Secures Series C Funding to Advance Oncologic Surgery Innovation

Vensana Capital® Portfolio News

Trinity Capital Inc. Provides $25 Million Growth Capital To Moxe Health

Vensana Capital® Portfolio News

Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.

Vensana Capital® Portfolio News

Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Vascular Imaging Platform

Vensana Capital® Portfolio News

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

Vensana Capital® Portfolio News

SpyGlass Pharma Completes $90 Million Series C Financing to Advance Novel Treatments for Glaucoma and other Chronic Ophthalmic Diseases

Vensana Capital® Portfolio News

Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability

Vensana Capital® Portfolio News

Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

40

Level I Clinical Trials

32

Strategic Financings

31

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
MedTech Strategist: Vensana Capital Closes Its Third Medtech Fund for $425 Million
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
Medtech Talk Podcast: Host Justin Klein with Douglas Kelly on the Value of Innovation and Breakthrough Designation
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2025 Vensana Capital Management, LLC | Privacy | Terms & Conditions